Feng et al. studied the targeting of colorectal cancer with small-molecule inhibitors of ALDH1B1, while Bu et al. targeted ALDH1 in triple-negative breast carcinoma [19,20]. Here, ALDH1B1 is linked to triple-negative breast carcinoma.